跳至主要内容
临床试验/NCT03513705
NCT03513705已完成不适用

Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1): a Multicenter Stepped-wedge Cluster Randomized Controlled Trial

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)17 个研究点 分布在 1 个国家目标入组 4,000 人开始时间: 2018年5月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
4,000
试验地点
17
主要终点
1-year overall survival

研究概览

简要总结

PACAP-1 will evaluate to what extent an enhanced implementation of best practices in pancreatic cancer care leads to a prolonged survival and improvement of quality of life as compared to current practice.

详细描述

Rationale:

The Dutch Pancreatic Cancer Project (PACAP) is an initiative of the Dutch Pancreatic Cancer Group and was officially launched in July 2014. PACAP is 1 of the largest nationwide collaborative outcomes registration and biobanking projects on pancreatic and periampullary cancer worldwide and includes the Dutch Pancreatic Cancer Audit (DPCA), the Patient Reported Outcome Measures (PROMs), an online expert panel, and the Netherlands Cancer Registry (NCR, Netherlands Comprehensive Cancer Organization; IKNL). During the first 3 years of PACAP, regional variations in treatment and guideline (non-)compliance were observed. These differences may lead to differences in survival and quality of life of pancreatic cancer patients throughout the Netherlands. From PACAP data and literature, best practices for pancreatic cancer care have been identified.

Objective:

The aim of PACAP-1 is to evaluate to what extent an enhanced implementation of best practices in pancreatic cancer care in the Netherlands leads to a prolonged survival and improvement of quality of life as compared to current practice.

Study design:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •All pancreatic cancer patients

排除标准

  • •There are no specific exclusion criteria
  • •Inclusion Criteria clusters:
  • •All 17 centers of the DPCG. These centers each perform >20 pancreatoduodenectomies (PDs) annually. Each center already has a coordinating role for pancreatic cancer for its region. It is expected that the enhanced implementation of best practices will have an impact in the entire local network
  • •Exclusion Criteria clusters:
  • •There are no specific center exclusion criteria

研究组 & 干预措施

Best practice

Experimental

Enhanced implementation of best practices in pancreatic cancer care

干预措施: Best practices in pancreatic cancer care (Other)

Current practice

No Intervention

Pancreatic cancer care according to current practice

结局指标

主要结局

1-year overall survival

时间窗: 1-year

Overall survival 1-year after diagnosis of pancreatic cancer

次要结局

  • Use of smartphone application(Through study completion, on average up to 25 months)
  • Registry outcomes(Through study completion, on average up to 25 months)
  • Effect of implementation of best practices(Through study completion, on average up to 25 months)
  • 5-year overall survival(5-year)
  • Complications(Through study completion, on average up to 25 months)
  • 3-year overall survival(3-year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

M.G. Besselink

Prof. Dr.

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

研究点 (17)

Loading locations...

相似试验